|
000
| 02165nam 2200373zi 4500 |
|---|
| 001 | 9.939161 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20240709134031 |
|---|
| 006 | m o d f |
|---|
| 007 | cr |n||||||||| |
|---|
| 008 | 240610e202401##oncd ob f00| 0 eng d |
|---|
| 020 | |a9780660722801 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH14-620/2024E-PDF |
|---|
| 245 | 00|aEvaluation of the Pharmaceutical Drugs Program / |cprepared by the Office of Audit and Evaluation, Health Canada and the Public Health Agency of Canada. |
|---|
| 264 | 1|a[Ottawa] : |bHealth Canada, Public Health Agency of Canada = Santé Canada, l'Agence de la santé publique du Canada, |cJanuary 2024. |
|---|
| 264 | 4|c©2024 |
|---|
| 300 | |a1 online resource (ii, vi, 38, [11] pages) : |bcharts |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Évaluation du Programme des médicaments pharmaceutiques. |
|---|
| 504 | |aIncludes bibiographical references (pages [pages 8-11]). |
|---|
| 520 | |a"Covering activities from 2017-18 to 2022-23, the evaluation examined pharmaceutical drugs for human and veterinary use, including both prescription and non-prescription drugs. Activities related to biologics, radiopharmaceuticals, natural health products and medical devices were excluded from this evaluation, as there are separately planned evaluations to assess these other health products"--page iii. |
|---|
| 610 | 10|aCanada. |bHealth Canada|xEvaluation. |
|---|
| 610 | 20|aPublic Health Agency of Canada|xEvaluation. |
|---|
| 650 | 0|aPharmaceutical policy|zCanada|xEvaluation. |
|---|
| 710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
|---|
| 710 | 2 |aPublic Health Agency of Canada, |eissuing body. |
|---|
| 775 | 08|tÉvaluation du Programme des médicaments pharmaceutiques / |w(CaOODSP)9.939162 |
|---|
| 856 | 40|qPDF|s1,022 KB|uhttps://publications.gc.ca/collections/collection_2024/sc-hc/H14-620-2024-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/corporate/transparency/corporate-management-reporting/evaluation/pharmaceutical-drugs-program.html |
|---|